Loading patent…
AssigneesSastra Deemed University, Versitech Limited
InventorsPrasanna NEELAKANTAN, Adline Princy SOLOMON, Karthi SHANMUGAM
Estimating the term…
The present invention relates to a compound for treating fungal disease, wherein said compound provide target-specific inhibition of fungal adhesion, biofilm formation, and filamentation without affecting their growth, at very low concentration. The compound of the present invention is selected from FDA approved drugs Cangrelor. Further, the present invention provides a composition comprising compound of the present invention and a pharmaceutically acceptable carrier. Further, the present invention provides a method of treating fungal infections using the compound and/or composition of the present invention. Furthermore, uses of the compound and/or composition is also being provided in the present disclosure.
A compound for treating fungal diseases, wherein said compound provide target-specific inhibition of fungal adhesion, biofilm formation, and filamentation without affecting their growth at very low concentration;
Use of an antifungal compound for treating fungal diseases selected from oral and vaginal candidiasis, wherein said compound is an FDA approved drug, Cangrelor.
Dependencies are inferred from the claim text.